Zavesca — Medica
Other conditions
Preferred products
- Cerdelga
- generic miglustat
Initial criteria
- Patient meets the standard Gaucher Disease Substrate Reduction Therapy – Miglustat (Zavesca) Prior Authorization criteria
Approval duration
1 year
Other conditions
1 year